EUVIMEDEUVIMED entdecken
Kommentar

Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy

Sarah S Long

Evidence Based Medicine · 2013

DOI: 10.1136/eb-2012-100674 ↗

Kurz gefasst

Kommentar in der Zeitschrift Evidence Based Medicine, 2013. Verfasst von Sarah S Long. Beteiligte Einrichtung: Section of Infectious Diseases, St Christopher's Hospital for Children, Philadelphia, PA 19134, USA. sarah.long@drexelmed.edu. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcyclovirAntiviral AgentsFemaleHerpes SimplexHumansMale

Substanzen

Antiviral AgentsAcyclovir

Autor:innen und Institutionen

  • Section of Infectious Diseases, St Christopher's Hospital for Children, Philadelphia, PA 19134, USA. sarah.long@drexelmed.edu

Zitieren

APA

Long, S. S. (2013). Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy. Evidence Based Medicine. https://doi.org/10.1136/eb-2012-100674

Vancouver

Long SS. Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy. Evidence Based Medicine. 2013. doi:10.1136/eb-2012-100674

BibTeX
@article{Long2013,
  author = {Long, Sarah S},
  title = {Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy},
  journal = {Evidence Based Medicine},
  year = {2013},
  doi = {10.1136/eb-2012-100674}
}
Kostenlos starten →